Q2 2026 Revenue Projection -- Projected at $250,000, primarily from laboratory services and minimal GraftAssure IQ sales. Q2 ...

FDA progress for GraftAssureDx, registry momentum, launch timing, and cash burn outlook—read the key takeaways now.

PAVmed retains significant influence over Lucid Diagnostics, with approximately 15% common equity interest and 25% voting ...

Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% ...

Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total RevenueActive Commercial Cancer Center Customers Expand to 16 with Growing ...

Kiro, Spec Kit, Tessl, and Zenflow offer a more systematic and structured approach to developing with AI agents than vibe ...

In this second article in a series, we turn from the federal order itself to the state compliance problems it creates, particularly in ...

Carrying out the digital equivalent of spring cleaning a home isn’t just an opportunity to tidy up our online lives.

SeaStar Medical Holding Corporation (NASDAQ:ICU) is expanding its footprint in the pediatric acute kidney injury (AKI) market through continued Quellimmune adoption and education efforts. The company ...

Eli Lilly and Company today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound ...

Q1 2026 Earnings Call May 13, 2026 4:30 PM EDTCompany ParticipantsPeter Mariani - Chief Financial OfficerPhillip Chan - ...

Many of Pro's best features are useful for everyone that uses Windows, not just "professionals." ...